Skip to Content


Active substance(s): TELMISARTAN

PDF options:  View Fullscreen   Download PDF

PDF Transcript


Telmisartan 20mg film-coated tablet
Telmisartan 40mg film-coated tablet
Telmisartan 80mg film-coated tablet
Read all of this leaflet carefully before you start taking this medicine because it contains important
information for you.

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor or pharmacist or nurse.

This medicine has been prescribed for you only. Do not pass it on to others. It may harm them,
even if their signs of illness are the same as yours.

If you get any side effects talk to your doctor, pharmacist or nurse. This includes any possible
side effects not listed in this leaflet. See section 4.
What is in this leaflet:
What Telmisartan is and what it is used for
What you need to know before you take Telmisartan
How to take Telmisartan
Possible side effects
How to store Telmisartan
Contents of the pack and other information



Telmisartan belongs to a class of medicines known as angiotensin II receptor antagonists. Angiotensin II is
a substance produced in your body which causes your blood vessels to narrow, thus increasing your blood
pressure. Telmisartan blocks the effect of angiotensin II so that the blood vessels relax, and your blood
pressure is lowered.
Telmisartan is used to treat essential hypertension (high blood pressure). ‘Essential’ means that the high
blood pressure is not caused by any other condition.
High blood pressure, if not treated, can damage blood vessels in several organs, which could lead sometimes
to heart attack, heart or kidney failure, stroke, or blindness. There are usually no symptoms of high blood
pressure before damage occurs. Thus it is important to regularly measure blood pressure to verify if it is
within the normal range.
Telmisartan is also used to reduce cardiovascular events (i.e. heart attack or stroke) in patients who are at
risk because they have a reduced or blocked blood supply to the heart or legs, or have had a stroke or have
high risk diabetes. Your doctor can tell you if you are at high risk for such events.



Do not take Telmisartan
If you are allergic to telmisartan or any of the other ingredients of this medicine (listed in section 6).
If you are more than 3 months pregnant. (It is also better to avoid Telmisartan in early pregnancy –
see pregnancy section.)
If you have severe liver problems such as cholestasis or biliary obstruction (problems with the
drainage of the bile from the liver and gall bladder) or any other severe liver disease
If you have diabetes or impaired kidney function and you are treated with a blood pressure

lowering medicine containing aliskiren.
If any of the above applies to you, tell your doctor or pharmacist before taking Telmisartan
Warnings and precautions
Please tell your doctor if you are suffering or have ever suffered from any of the following conditions or

Kidney disease or kidney transplant
Renal artery stenosis (narrowing of the blood vessels to one or both kidneys).
Liver disease.
Heart trouble.
Raised aldosterone levels (water and salt retention in the body along with imbalance of various blood
Low blood pressure (hypotension), likely to occur if you are dehydrated (excessive loss of body water) or
have salt deficiency due to diuretic therapy ('water tablets'), low-salt diet, diarrhoea, or vomiting.
Elevated potassium levels in your blood.

Talk to your doctor, pharmacist or nurse before taking Telmisartan
if you are taking any of the following medicines used to treat high blood pressure:
an ACE-inhibitor (for example enalapril, lisinopril, ramipril), in particular if you have
diabetes-related kidney problems.
Your doctor may check your kidney function, blood pressure, and the amount of electrolytes (e.g.
potassium) in your blood at regular intervals.
See also information under the heading “DO NOT take Telmisartan”
You must tell your doctor if you think you are (or might become) pregnant. Telmisartan is not
recommended in early pregnancy, and must not be taken if you are more than 3 months pregnant, as it may
cause serious harm to your baby if used at that stage (see pregnancy section).
In case of surgery or anaesthesia, you should tell your doctor that you are taking Telmisartan.
Children and adolescents
The use of Telmisartan in children and adolescents up to the age of 18 years is not recommended.
As with all other angiotensin II receptor antagonists, Telmisartan may be less effective in lowering the
blood pressure in black patients.
Other medicines and Telmisartan
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Your doctor may need to change the dose of these other medicines or take other precautions. In some cases
you may have to stop taking one of the medicines. This applies especially to the medicines listed below
taken at the same time with Telmisartan:


Lithium containing medicines to treat some types of depression.
Medicines that may increase blood potassium levels such as salt substitutes containing
potassium, potassium-sparing diuretics (certain 'water tablets'), ACE inhibitors, angiotensin II
receptor antagonists, NSAIDs (non steroidal anti-inflammatory medicines, e.g. aspirin or
ibuprofen), heparin, immunosuppressives (e.g. cyclosporin or tacrolimus), and the antibiotic
Diuretics ('water tablets'), especially if taken in high doses together with Telmisartan , may lead to
excessive loss of body water and low blood pressure (hypotension).


If you are taking an ACE-inhibitor or aliskiren (see also information under the headings “DO
NOT take Telmisartan” and “Warnings and precautions”).

As with other blood pressure lowering medicines, the effect of Telmisartan may be reduced when you take
NSAIDs (non steroidal anti-inflammatory medicines, e.g. aspirin or ibuprofen) or corticosteroids.
Telmisartan may increase the blood pressure lowering effect of other medicines used to treat high blood
Telmisartan with food
You can take Telmisartan with or without food.
Pregnancy and breast-feeding
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your
doctor or pharmacist for advice before taking his medicine.
Your doctor will normally advise you to stop taking Telmisartan before you become pregnant or as soon as
you know you are pregnant and will advise you to take another medicine instead of Telmisartan.
Telmisartan is not recommended in early pregnancy, and must not be taken when more than 3 months
pregnant, as it may cause serious harm to your baby if used after the third month of pregnancy.
Telmisartan is not recommended for mothers who are breast-feeding, and your doctor may choose another
treatment for you if you wish to breast-feed, especially if your baby is newborn, or was born prematurely.
Driving and using machines
No information is available on the effect of Telmisartan on the ability to drive or operate machinery. Some
people feel dizzy or tired when they are treated for high blood pressure. If you feel dizzy or tired, do not
drive or operate machinery.
Telmisartan contains lactose
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before
taking this medicine.

HOW TO TAKE Telmisartan
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor
or pharmacist if you are not sure.
The recommended dose of Telmisartan is one tablet a day. Try to take the tablet at the same time each
day. You can take Telmisartan with or without food. The tablets should be swallowed with some water or
other non-alcoholic drink. It is important that you take Telmisartan every day until your doctor tells you
otherwise. If you have the impression that the effect of Telmisartan is too strong or too weak, talk to your
doctor or pharmacist.
For the treatment of high blood pressure, the recommended dose of Telmisartan for most patients is one
40 mg tablet once a day to control blood pressure over the 24-hour period. However sometimes your
doctor may recommend a lower dose of 20 mg or a higher dose of 80 mg. Telmisartan may also be used in
combination with diuretics ('water tablets') such as hydrochlorothiazide which has been shown to have an
additive blood pressure lowering effect with Telmisartan.

For reduction of cardiovascular events, the recommended dose of Telmisartan is one 80 mg tablet once a
day. At the beginning of the preventive therapy with Telmisartan 80 mg, blood pressure should be frequently
If your liver is not working properly, the usual dose should not exceed 40 mg once daily.
If you take more Telmisartan than you should
If you accidentally take too many tablets, contact your doctor, pharmacist, or your nearest hospital
emergency department immediately.
If you forget to take Telmisartan
If you forget to take a dose, do not worry. Take it as soon as you remember then carry on as before. If you
do not take your tablet on one day, take your normal dose on the next day. Do not take a double dose to
make up for a forgotten dose.
If you stop taking Telmisartan
Do not stop taking Telmisartan without talking to your doctor.
Medicines for high blood pressure may need to be taken for the rest of your life. If you stop taking
Telmisartan your blood pressure will return to the level it was before treatment in a few days.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist or nurse.



Like all medicines, this medicine can cause side effects, although not everybody gets them.
Some side effects can be serious and need immediate medical attention:
You should see your doctor immediately if you experience any of the following symptoms:
Sepsis* (often called "blood poisoning", is a severe infection with whole-body inflammatory
response), rapid swelling of the skin and mucosa (angioedema), severe allergic reaction (anaphylactic
reaction), allergic reaction (e.g. rash, itching, difficulty breathing, wheezing, swelling of the face or low
blood pressure); these side effects are rare but are
extremely serious and patients should stop taking the product and see their doctor immediately. If
these effects are not treated they could be fatal.
Possible side effects of Telmisartan
Common side effects (may affect up to 1 in 10 people):
Low blood pressure (hypotension) in users treated for reduction of cardiovascular events.
Uncommon side effects (may affect up to 1 to 100 people):
Urinary tract infections, upper respiratory tract infections (e.g. sore throat, inflamed sinuses, common cold),
deficiency in red blood cells (anaemia), high potassium levels, difficulty falling asleep, feeling sad
(depression), fainting (syncope), feeling of spinning (vertigo), slow heart rate (bradycardia), low blood
pressure (hypotension), in users treated for high blood pressure, dizziness on standing up (orthostatic
hypotension), shortness of breath, cough, abdominal pain, diarrhoea, discomfort in the abdomen, bloating,
vomiting, itching, increased sweating, drug rash, back pain, muscle cramps, muscle pain (myalgia), kidney
impairment including acute kidney failure, pain in the chest, feeling of weakness, and increased level of
creatinine in the blood.

Rare side effects (may affect up to 1 in 1,000 people):
Increase in certain white blood cells (eosinophilia), low platelet count (thrombocytopenia), low blood
sugar levels (in diabetic patients), feeling anxious, somnolence, impaired vision, fast heart beat
(tachycardia), upset stomach, dry mouth, abnormal liver function (Japanese patients are more likely to
experience these side effect), eczema (a skin disorder), redness of skin, hives (urticaria), severe drug rash,
joint pain (arthralgia), pain in extremity, tendon pain, flu-like-illness, decreased haemoglobin (a blood
protein), increased levels of uric acid, increased hepatic enzymes or creatine phosphokinase in the blood.
Very rare side effects (may affect up to 1 in 10,000 people):
Progressive scarring of lung tissue (interstitial lung disease) **
*The event may have happened by chance or could be related to a mechanism currently not known.
**Cases of progressive scarring of lung tissue have been reported during intake of telmisartan.
However, it is not known whether telmisartan was the cause.
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects
not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: By reporting side effects you can help provide more information on the
safety of this medicine.


Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton after “EXP”. The expiry date
refers to the last day of that month.
This medicine does not require any special storage conditions.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw
away medicines you no longer use. These measures will help protect the environment.



What Telmisartan contains

The active substance is telmisartan, each tablet contains 20mg/40mg/80mg telmisartan.
The other ingredients are:

Sodium Hydroxide
Povidone (K-25)
Lactose Monohydrate
Ferric oxide yellow (E172)
Magnesium Stearate
The film-coating contains:
Titanium Dioxide (E171)
Ferric oxide yellow (E172)
What Telmisartan looks like and contents of the pack

Telmisartan 20mg film-coated tablets are yellow, circular shaped film coated tablets with ‘20’ engraved on
one side and ‘T’ engraved on the other side.
Telmisartan 40 mg film-coated tablets are yellow, capsule shaped film coated tablets with ‘40’ engraved on
one side and ‘T’ engraved on the other side.
Telmisartan 80 mg film-coated tablets are yellow, capsule shaped film coated tablets with ‘80’ engraved on
one side and ‘T’ engraved on the other side.
Telmisartan 20 mg is available in blister packs containing 14, 15, 28, 30, 56, 60, 90 or 98 tablets.
Telmisartan 40 mg is available in blister packs containing 14, 15, 28, 30, 56, 60, 90 or 98 tablets.
Telmisartan 80 mg is available in blister packs containing 14, 15, 28, 30, 56, 60, 90 or 98 tablets.
Not all pack sizes may be marketed in your country.
Marketing Authorisation Holder and Manufacturer
STADA Arzneimittel AG
Stadastraße 2-18
61118 Bad Vilbel
This leaflet was last revised in June/2015.

+ Expand Transcript

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.